Background The incidence and virulence of Clostridium difficile infection (CDI) are on the rise. The characteristics of patients who develop CDI following colorectal resection have been infrequently studied.
Introduction
Clostridium difficile infection (CDI) results in approximately 250,000 hospitalizations 1 and an estimated $750 million to $3.2 billion in medical costs annually in the USA. [2] [3] [4] Although originally thought to be only associated with antibiotic use, CDI is now also associated with hospitalization and residence in long-term care facilities. 5 -7 In fact, the most common cause of diarrhea in a hospitalized patient is CDI. Rates of CDI are also on the rise, 8 with the spectrum of clinical presentation ranging from an asymptomatic carrier state to fulminant colitis. 5 Furthermore, the virulence of CDI is increasing. National mortality data suggest that CDI-related mortality has increased in the USA between 1999 and 2004, from 5.7 deaths per million population to 23.7 
per million in 2004.
This association has been linked, in part, to the use of bowel preparation with oral antibiotics. 13 Numerous studies have assessed the relationship between inflammatory bowel disease (IBD) and CDI showing higher rates of CDI and worse outcomes in those with IBD compared with controls. 14 Few reports have described the magnitude, risk factors, and outcomes of CDI in patients who have undergone colorectal procedures for other disease processes. 12 Identification of colorectal surgery patients at high risk for CDI can help target preventive measures and decrease the burden associated with this increasingly prevalent disease. Using information from the University HealthSystem Consortium (UHC) Clinical Database, we examined the incidence, 30-day outcomes, and patient-related risk factors for CDI among patients undergoing colorectal resection for cancer, IBD, diverticular disease, and benign tumors.
Materials and Methods

Source of Data
The UHC Clinical Database collects inpatient data from participating academic medical centers and their affiliates, comprising nearly 95 % of US nonprofit medical centers. Data on all patients hospitalized at participating institutions are submitted to the database. Variables collected include International Classification of Diseases, 9th edition (ICD-9) codes for diagnoses and procedures, physician specialty, length of stay, risk-adjusted severity of illness scores, and hospitalassociated costs. The UHC converts hospital charges into cost estimates based on federal-wage data for each hospital location, allowing for meaningful cost comparisons between centers, regardless of hospital location.
Following exemption status by the University of Massachusetts Medical Center Institutional Review Board, the UHC database was queried for adult patients, 18 years or older, with procedure codes for colorectal resection (ICD-9 codes 17. 
Outcomes Measures and Predictors of CDI
The primary outcome of interest was CDI, defined by a nonprimary ICD-9 diagnosis of 0.845 from the index hospitalization or primary diagnosis at readmission within 30 days of the patient's index hospital discharge. Secondary endpoints were non-CDI postoperative complications, reoperation, intensive care unit (ICU) admission and duration, length of hospital stay (LOS), discharge status, total direct hospital costs (as reported by UHC), and 30-day in-hospital all-cause mortality rates. To determine the risk factors for CDI, we performed univariate screening of potential covariates and subsequent multivariable logistic regression including those factors deemed to be associated with CDI during our univariate analyses. Potential covariates included age, gender, race, insurance status, comorbid diagnoses (based on ICD-9 diagnosis codes), 3M © APR-DRG Admission Severity of Illness Score (3M Health Information Systems, Salt Lake City, UT), recoded into low (minor and moderate) and high (major and extreme) for ease of analysis, inpatient postoperative complications (e.g., stroke, pneumonia, hemorrhage/hematoma, reopening of surgical wound, cellulitis, urinary tract infection, myocardial infarction, venous thromboembolism, sepsis), ICU admission rate after initial procedure, index hospitalization LOS, index hospitalization discharge status (home vs. nonhome), indication for procedure (diagnosis type), minimally invasive use (vs. open surgery), and ostomy creation. Postoperative complications were coded in the database by UHC.
Data Analysis
Univariate and multivariable regression analyses were used to assess the demographic, clinical, and perioperative risk factors for CDI. Selected continuous variables were analyzed by Student's t test, while differences in categorical variables were examined through the use of chi-square tests. Selection of covariates for use in the multivariable regression models was based upon a priori knowledge and significant associations observed in our univariate analyses. Our regression models were adjusted for age, sex, race, admission severity of illness score, insurance status, procedure type, and hospital-volume category. All analyses were conducted with the use of Stata© IC version 12.1.
Results
Cohort Characteristics and CDI Risk Factors
Over the study period, 84,648 adult men and women (≥18 years) from 215 hospitals met our inclusion criteria. Of these, 1.5 % developed CDI. The average age of the study population was 60 years, and 50 % were women. Between 2009 and 2012, postcolorectal resection CDI rates ranged from 1.5 to 1.6 % (p>0.05) (Fig. 1) .
Patients who developed CDI were older and more likely to be female (Table 1) . There were higher rates of public insurance among CDI patients. Patients with CDI were more likely to have been previously diagnosed with hypertension, diabetes, anemia, chronic obstructive pulmonary disease, congestive heart failure, renal disease, liver disease, and peripheral vascular disease in comparison to those without CDI. Most patients underwent elective resections, but emergency surgery occurred in approximately 30 % of the CDI group compared with 15 % of the non-CDI group (Table 2) . Patients in the CDI group had longer inpatient LOS prior to surgery and were more likely to undergo open surgery than non-CDI patients. In order to assess the independent patient-related predictors of CDI, multivariable logistic regression was performed. The strongest factor associated with CDI was preoperative inpatient LOS, with LOS >1 week conferring over four times the risk than patients who were admitted on the same day as surgery (Table 3) . Age ≥80 years, female gender, public insurance, high severity of illness, IBD, diverticular disease, colectomy (compared with proctectomy), open surgery, and emergent procedure status were significant, independent predictors of postcolorectal resection CDI.
Outcomes
Non-CDI complications occurred in nearly one fourth of CDI patients and only one tenth of patients who did not develop CDI (Table 4) . ICU admission was far more common in CDI patients, and when it occurred, the CDI group had a median stay of 1 day longer. Eight percent of the CDI group underwent reoperation subsequent to the initial procedure, compared with only 3 % in the non-CDI group. Inpatient length of stay and total direct hospital cost for CDI patients were about twice that of non-CDI patients. About one in three CDI patients was discharged to a rehabilitation or skilled nursing facility, compared with only one in ten of the non-CDI group. Overall, readmission rates were significantly higher in the CDI group (23 vs. 13 %, p<0.001). Inpatient mortality was much higher for CDI patients (5 vs. 1 %, p<0.001). After adjusting for relevant confounders, the odds of non-CDI complications, ICU admission, reoperation, abdominal drain placement, nonhome discharge, and mortality were between two and three times higher in the CDI group (Table 4) . On average, ICU stay and index LOS were 5.0 and 8.4 days longer, respectively, and total direct hospital cost was $14,130 higher in CDI patients on adjusted analysis. Finally, the odds of all-cause inpatient mortality within 30 days were more than twice as high (OR 2.12; 95 % CI 1.59, 2.82) in CDI patients compared with the non-CDI group. 
Discussion
Overview
In this study, we examined the occurrence of CDI in a large observational cohort of adult patients who underwent colorectal resection for both benign and malignant conditions. To our knowledge, this is one of the largest reports to assess CDI patients undergoing colorectal resection. We demonstrated that CDI following colorectal resection occurred in 1.5 % of patients but was responsible for a substantial burden on the healthcare system. Over the span of the study, the rates of CDI did not change significantly. Several strong predictors of postcolorectal resection CDI were identified, including older age, female gender, public insurance, non-cancer surgical indication, emergent procedure status, open surgery, colon resection (compared with rectal), and non-same-day surgery, which had the strongest association. On both crude and multivariable analysis, patients with CDI were more likely to have postoperative complications, require ICU level care, reoperation, or percutaneous drain placement, be hospitalized over a week longer, be discharged to a place other than home, and be readmitted within 30 days of initial discharge. In addition, patients with CDI, on average, had total direct hospital cost of $14,130 higher than non-CDI patients.
Rates of CDI Infection
The reported incidence of CDI among all hospitalized patients ranges from 0.1 to 2 %. 5 Among general surgery patients, the rate of postcolorectal resection CDI ranged from less than 1 % to as high as nearly 6 %, 3, 12, 15 consistent with our findings. During the study period, we did not find a significant trend in the incidence of new episodes of CDI. Population-based studies have found an increase in CDI between 2001 and 2010 in the USA, along with persistently elevated mortality rates and a rise in total colectomy rates. 8 An analysis of data from the nationwide inpatient sample found a marginal increase in postsurgical CDI, from 0.5 to 0.6 % between 1999 and 2003. 3 A possible explanation for not finding an increase in CDI incidence in the present study may have been due to the relatively short time frame studied (2008-2011). Longitudinal cohort studies may be required to analyze trends in CDI among postsurgical patients.
Factors Associated with the Development of CDI An inpatient setting, previous or current antibiotic treatment, older age, and immunocompromised status are some of the known risk factors for CDI among the general patient population. Recent studies have even suggested an association between the use of proton pump inhibitors and occurrence of CDI. 16, 17 We found several risk factors among our cohort; some of which are consistent with those found in the general patient population, including older age, higher illness severity, preoperative inpatient stay, and emergent admission status, the strongest being preoperative inpatient stay. The strong association between longer preoperative LOS and CDI occurrence is expected, as increased time in the inpatient setting increases a patient's exposure risk profile. To limit the inclusion of patients undergoing a resection for CDI, we limited the study population to those with either a primary or secondary diagnosis of cancer, diverticular disease, IBD, or benign tumor and excluded patients with a primary diagnosis of CDI at the index hospitalization. It is important to note that despite adjustment for this strong risk factor, the association between additional factors, such as public insurance, IBD, diverticular disease, and colon (vs. rectal) resection and CDI, persisted. The identification of these additional risk factors will allow for the implementation of more specific preventive measures that may reduce the burden of CDI among postsurgical patients.
The etiology of the association between public insurance and CDI is poorly understood. Previous reports have also described this association. 18 Other hospital-acquired infections are also more common among patients with public insurance who have undergone a colectomy. 19 There are likely unmeasured confounders or mediators related to being publically insured, such as access to care, 20 poorer control of comorbid conditions, or less compliance with medications that cannot be adjusted for given the nature of our data. Nevertheless, publically insured patients represent a vulnerable population in which targeted prevention strategies may provide some utility.
The relationship between IBD and CDI has been well studied. A recent systematic review of 42 studies evaluating this relationship found that CDI is more common in patients with IBD likely related to chronic immunosuppression and antibiotics treatment.
14, 21 We found patients with IBD to have a 1.7 times higher risk of developing CDI than those undergoing cancer surgery. A slightly weaker, yet significant, association was found with diverticular disease. We postulate that this association may reflect changes in the microbial milieu due to prior or current antibiotic treatment for diverticulitis. Unfortunately, given the limitations of the UHC database, we are unable to report on the degree of disease activity and frequency/dosage of antibiotic usage. Poor Outcomes
We observed overwhelmingly poor outcomes in patients with CDI, consistent with previous studies on general inpatient populations. Patients with CDI have been shown to experience higher mortality, 22, 23 increased LOS, 7, 22 and higher rates of readmission 22 than patients without CDI. It is difficult to determine, however, if these poor outcomes contributed to the acquisition of CDI or were a result of the infection itself. Though the literature supports colorectal surgery as a risk factor for CDI, 3, 15 we cannot comment on differences and outcomes between these and nonsurgical patients.
Possible explanations for our observed outcomes could be related to the surgery itself. Since mild diarrhea is common in postoperative patients, the diagnosis and treatment of CDI may be delayed. Furthermore, patients with a diverting stoma may not have adequate stool from the colon to send for testing. In a postoperative patient with worsening clinical status, CDI may not be high on the differential. Initial management of more relevant complications, such as anastomotic leak and non-CDI intraabdominal infection, is usually the administration of broad-spectrum antibiotics with anaerobic coverage, which may actually increase the frequency and severity of CDI. Regardless, given the increased incidence of CDI noted in prior studies 3, 8, 9 and its devastating outcomes, this infection needs to be kept high on the differential in the postoperative setting.
Hospital Costs
A recent systematic review by Ghantoji et al. evaluated the costs associated with CDI. 22 These investigators found an incremental cost of $2,871 to $4,846 per each case of primary CDI and $13,655 to $18,067 per case of recurrent CDI (corrected for inflation to 2008 US dollars based on consumer price index). Most of the studies included in this review evaluated patients with IBD, surgical patients, and intensive care unit patients. Our findings of an average cost of $14,130 higher cost in the CDI group may be explained by the 8-day average increased length of stay. This finding may also be attributed to the increase in resource utilization which often accompanies medical and surgical complications. Regardless of the etiology, our data support previous reports of a significant economic burden of CDI on the health care system. The present findings warrant further studies into the utilization of healthcare resources for both the prevention and early diagnosis of CDI.
Study Strengths and Limitations
This study has several strengths. Not only did we describe the recent trends in the magnitude of CDI but we also highlighted important yet easily identifiable risk factors for its occurrence.
Furthermore, we reported the outcomes of CDI in this patient population. However, our study is not without limitations. First, although the data were limited to 2008 and beyond, we believe the database does allow for a detailed assessment of morbidity and cost outcomes related to CDI. Second, given the administrative nature of the data, we cannot say with absolute certainty that patients did not have CDI prior to their hospital admission. In order to account for this, patients included in the study were those with a primary or secondary diagnosis of cancer, IBD, diverticular disease, or benign tumors. Patients with a primary diagnosis of CDI were excluded from the study. Furthermore, because of the inability to link to outpatient medication records, such as Medicare Part D, we are unable to state with absolute certainty that CDI, if present, would have been eradicated prior to the planned elective procedure. Third, some patients may also not have had CDI reported as a billable diagnosis if there were several other diagnoses present with higher reimbursements, leading to a possible underestimation of the true incidence of postcolorectal resection CDI. Despite these limitations, we believe that these results emphasize the significance of CDI in the postcolectomy setting and its burden on the colorectal surgery population.
Conclusion
As the incidence and virulence of CDI continues to rise, providers should place CDI high on the differential when patients develop signs and symptoms consistent with the diagnosis in the postoperative setting. The identification of highrisk patients at the time of surgery allows for the implementation of targeted strategies to reduce infection risk. Interventions may include private rooms, ensuring nursing and ancillary care staff are not also caring for CDI patients, and prompt analysis of stool samples when CDI is suspected. Novel therapies, such as stool transplant, may offer a treatment option to high-risk patients that can translate into a reduction in the complications and mortality associated with CDI. Certainly, these poor outcomes warrant further investigation of prevention and treatment strategies. Finally, although postoperative CDI is a relatively rare occurrence in colorectal patients, the morbidity, mortality, and costs associated with CDI place a significant burden on the healthcare system.
